Literature DB >> 25965235

Screening for hepatitis C.

Charlie M Wray1, Andrew M Davis1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25965235     DOI： 10.1001/jama.2015.2833

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Treatment strategies for chronic hepatitis C prior to and following liver transplantation.

Authors:  Ryan B Perumpail; Thomas A Hahambis; Avin Aggarwal; Zobair M Younossi; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2016-01-08

Review 2.  Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis.

Authors:  Qiu-Feng He; Qiong-Fang Zhang; Da-Zhi Zhang
Journal:  Dig Dis Sci       Date:  2016-09-12       Impact factor: 3.199

3.  Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease.

Authors:  George Cholankeril; Eric R Yoo; Ryan B Perumpail; Andy Liu; Jeevin S Sandhu; Satheesh Nair; Menghan Hu; Aijaz Ahmed
Journal:  Diseases       Date:  2017-09-26

Review 4.  Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.

Authors:  George Cholankeril; Mairin Joseph-Talreja; Brandon J Perumpail; Andy Liu; Eric R Yoo; Aijaz Ahmed; Aparna Goel
Journal:  J Clin Transl Hepatol       Date:  2017-09-14

Review 5.  Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.

Authors:  Chiranjeevi Gadiparthi; George Cholankeril; Brandon J Perumpail; Eric R Yoo; Sanjaya K Satapathy; Satheesh Nair; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.